Trials / Unknown
UnknownNCT02831543
Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 354 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A phase Ⅲ, multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Motireb 5/100 mg | |
| DRUG | Mosapride citrate | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-01-01
- Completion
- 2017-06-01
- First posted
- 2016-07-13
- Last updated
- 2016-07-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02831543. Inclusion in this directory is not an endorsement.